Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

Pfizer launches legal action to block Xeljanz copies in India

September 9, 2016 Medical Communications, Sales and Marketing Pfizer, Sun Pharma, Xeljanz, Zydus Cadila, rheumatoid arthritis

Pfizer has pre-emptively sued a number of India-based drug companies including Sun Pharma and Zydus Cadila to block any attempts …
News
fda2outsideweb

FDA approves Dechra’s generic antibiotic

September 9, 2016 Medical Communications, Sales and Marketing Dechra, Putney, antiobiotic, generic

Dechra has announced that the US Food and Drug Administration (FDA) has approved its generic antibiotic. The product will be …
News

Apple introduce stricter entry requirements for health apps

September 8, 2016 Medical Communications, Research and Development Apple, Guidelines, apps, iphone, strict

Apple has toughened its stance on health and medical apps that can be bought and downloaded on the iOS App …
News
c_ssilver-fotolia_ebr_jul_2014

Clinical Trial Transparency

September 8, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trial, clinical trial transparency, transparency

Amid the global political and economic turmoil taking place, one small pharma story got much less attention than it should …
Feature
ole_isacson

Pfizer appoints new chief scientific officer for neuroscience research

September 7, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Ole Isacson has been named as the chief scientific officer at Pfizer’s neuroscience research unit. He will continue to …
Appointment
top_ten

Top ten stories in the pharmaceutical industry this week

September 2, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmafile.com, top ten

As Mylan is left reeling from the backlash on its EpiPen price increase in the US, many lost their jobs …
News

FDA fast track designation for Biogen’s investigational Alzheimer’s treatment

September 2, 2016 Medical Communications, Research and Development Alzheimer's, Alzheimer’s, Biogen, FDA, aducanumab, fast track

Biogen has announced that its investigational Alzheimer’s disease treatment aducanumab has been granted fast track designation by the FDA. The …
News
amgen_flag

Amgen’s leukaemia treatment given FDA thumbs up for use in paediatric patients

September 2, 2016 Medical Communications, Sales and Marketing Amgen, FDA, blincyto, leukaemia

Amgen has announced that the FDA has approved the supplemental Biologics License Application for Blincyto (blinatumomab) in the treatment of …
News

NICE recommends Bayer’s Xofigo for prostate cancer treatment

September 2, 2016 Medical Communications, Sales and Marketing Bayer, NICE, approval, prostate cancer, recommendation, xofigo

NICE has issued final draft guidance recommending Bayer’s Xofigo (radium-223 dichloride) for the treatment of prostate cancer. Previously, the drug …
News
abpi_reception_right

ABPI welcomes Roche back into the fold eight years after suspension

September 1, 2016 Medical Communications, Research and Development ABPI, Roche, rejoin, suspension

Less than a decade after the company was suspended, Roche has now successfully re-joined the Association of the British Pharmaceutical …
News

Sepha is fast packing with a new EZ Blister upgrade.

September 1, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Packaging Equipment Specialist, Sepha, has released a functional upgrade for one of its original products, EZ Blister, the lab scale …
News
Press release
cloud

Cloud on the horizon: Cloud computing and the clinical trial

September 1, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cloud Computing, ICON, clinical trials, ibm

 Originally published in the September edition of Pharmafocus, Matt Fellows investigates how cloud computing may just be the answer the …
Feature

Eli Lilly elects Jamere Jackson to board of directors

September 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, appointment

Eli Lilly has elected Jamere Jackson to its board of directors, effective 1 October, where he will serve on the …
Appointment

Recipharm establishes long term supply agreement with Tillotts Pharma AG

August 31, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Recipharm, the contract development and manufacturing organisation (CDMO), announces that it has entered into a long term supply agreement with …
News
Press release
pharmafocus_sept_2016_cover

The September issue of Pharmafocus is now live!

August 31, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myer's Squibb, Bristol-Myers Squibb, CDF, Cancer Drugs Fund, Cloud Computing, Pharmafocus, Pharmafocus new issue, brexit, clinical trial transparaency, opdivo

The latest edition of Pharmafocus is available online now. In this issue, we explore the future of the clinical trial …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026